Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Castleman Disease × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 2 Sarcoma, Kaposi 1 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, AIDS-Related 1 Lymphoma 1 HIV Infections 1 Congenital Abnormalities 1 Castleman Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00127569 2007-01-12

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

French National Agency for Research on AIDS and Viral Hepatitis

Phase 2 Terminated

LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡